Results 151 to 160 of about 262 (178)

Minimally invasive sacroiliac joint fusion: Primary endpoint results from the prospective, multicenter STACI study

open access: yesPM&R, EarlyView.
Abstract Background Chronic sacroiliac joint (SIJ) pain is highly debilitating. Minimally invasive SIJ fusion has become a commonly performed surgical treatment for SIJ pain, with level I evidence showing clinically significant improvements in pain, function, and quality of life and a low adverse event rate.
Jacqueline Weisbein   +11 more
wiley   +1 more source

Botulinum toxin use in patients with neurological disorders: A U.S.‐based claims database analysis

open access: yesPM&R, EarlyView.
Abstract Background and Objective Real‐world evidence describing long‐term persistency with botulinum toxin (BoNT) therapy is limited. We assessed treatment patterns and persistency with BoNT in clinical practice over 2 years. Design Retrospective, longitudinal, claims database analysis. Setting Medical claims data from the Merative MarketScan database
David M. Simpson   +4 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

The Effect of Krocina™ on Decreasing Substance User Withdrawal Syndrome, Craving, Depression and Stress: A Double-Blind Randomized Parallel Clinical Trial

Substance Use and Misuse, 2022
Due to the association between substance use abstinence with some psychological syndromes, the use of herbal medicines such as Crocus sativus L. have been considered as a proper approach to controlling withdrawal syndrome. The present study aimed to identify the effect of Krocina™ in reducing withdrawal symptoms, craving, depression, stress, anxiety ...
Hamid Jomehpour   +2 more
exaly   +3 more sources

Pharmacological management of psychoactive substance withdrawal syndrome

Drugs & Therapy Perspectives, 2021
Medications are available to manage alcohol and drug withdrawal, but they are underutilized. Only a handful, such as methadone, buprenorphine, clonidine, or benzodiazepines (chlordiazepoxide, lorazepam, or diazepam), are prescribed. Our objective was to provide an adjusted, inclusive, critical review of the clinical benefits of medications studied for ...
Dimy Fluyau   +4 more
openaire   +1 more source

[Pharmacotherapy of substance dependence and withdrawal syndromes].

Therapeutische Umschau. Revue therapeutique, 2009
Substance use disorders (SUD) include substance abuse and dependence as well as acute intoxication, withdrawal, and various psychiatric disorders. In the course of the SUD, severe comorbid disorders and somatic consequences can occur. The treatment of withdrawal symptoms focuses on the relief of immediate symptoms and the prevention of complications ...
Walter, Marc, Wiesbeck, Gerhard A.
openaire   +2 more sources

Understanding barriers to timely identification of infants at risk of neonatal opiate withdrawal syndrome

Journal of Maternal-Fetal and Neonatal Medicine, 2021
Meghan P Howell, Stacy S Drury
exaly  

Home - About - Disclaimer - Privacy